Product residue present adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From October 2013 to June 2026, FDA received 5,232 adverse event reports that record the MedDRA preferred term Product residue present. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 544 reports in the 12 months to June 2026 and 621 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 1 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 149 drug pages with 5 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Product residue present name as a suspect product, in order of name
Drug	Class	Reports with this term
Adalimumab	Tumor necrosis factor blocker	9
Advair Diskus	Corticosteroid	6
Afinitor	Kinase inhibitor	10
Afrezza	Insulin	7
Albuterol	beta2-Adrenergic agonist	7
Albuterol sulfate	beta2-Adrenergic agonist	22
albuterol sulfate HFA	beta2-Adrenergic agonist	6
Allegra Allergy	Histamine-1 receptor antagonist	5
Allegra D-12 Hour		51
Allegra-D	Histamine-1 receptor antagonist	8
Allegra-D 24 Hour		43
Ampyra	Potassium channel blocker	7
Anoro Ellipta	Anticholinergic	8
Apriso	Aminosalicylate	8
Azopt	Carbonic anhydrase inhibitor	8
Breo Ellipta	Corticosteroid	10
Budesonide	Corticosteroid	10
Buprenorphine	Partial opioid agonist	6
Bupropion	Aminoketone	15
Bupropion hydrochloride	Aminoketone	58
Carbamazepine	Mood stabilizer	16
Carbidopa and levodopa	Aromatic amino acid	5
Carbidopa levodopa	Aromatic amino acid	5
Cholestyramine		42
Ciclopirox		12
Clopidogrel	P2Y12 platelet inhibitor	7
CombiPatch (estradiol/norethindrone acetate transdermal system)	Estrogen	127
Concerta	Central nervous system stimulant	13
Creon		13
Daytrana	Central nervous system stimulant	11
Depakote	Anti-epileptic agent	27
Desvenlafaxine	Serotonin and norepinephrine reuptake inhibitor	21
Desvenlafaxine succinate	Serotonin and norepinephrine reuptake inhibitor	29
Desvenlafaxine succinate monohydrate		7
Dexycu		28
Diclofenac sodium	Nonsteroidal anti-inflammatory drug	5
Diltiazem hydrochloride	Calcium channel blocker	9
Divalproex sodium	Anti-epileptic agent	16
Dotarem	Gadolinium-based contrast agent	34
Eliquis	Factor Xa inhibitor	10
Enbrel	Tumor necrosis factor blocker	11
Estradiol	Estrogen	36
Estradiol Transdermal System	Estrogen	51
Farxiga	Sodium-Glucose cotransporter 2 inhibitor	5
Fentanyl	Opioid agonist	5
Fentanyl Transdermal System		17
Filsuvez		6
Fosrenol	Phosphate binder	25
Gabapentin	Anti-epileptic agent	7
Genotropin		6
Gocovri	Influenza A M2 protein inhibitor	8
Gralise		7
Humira		13
Hydromorphone		6
Hydromorphone hydrochloride	Opioid agonist	11
Hysingla ER	Opioid agonist	6
Ibrance	Kinase inhibitor	7
Imvexxy		144
Inbrija	Aromatic amino acid	559
Infliximab	Tumor necrosis factor blocker	14
Intuniv	Central alpha-2 adrenergic agonist	5
Janumet	Biguanide	23
Januvia	Dipeptidyl peptidase 4 inhibitor	18
Klor-Con	Osmotic laxative	11
Kombiglyze Xr		6
Latanoprost	Prostaglandin analog	6
Lialda	Aminosalicylate	33
Lidocaine	Amide local anesthetic	6
Lipiodol	Radiographic contrast agent	7
Lokelma		14
Losartan potassium	Angiotensin 2 receptor blocker	5
Lotemax	Corticosteroid	7
Lumify		15
Mens Rogaine		5
Mens Rogaine Extra Strength		64
Mens Rogaine Extra Strength Unscented	Arteriolar vasodilator	6
Mesalamine	Aminosalicylate	50
Mesalazine		12
Metformin	Biguanide	25
Metformin hydrochloride	Biguanide	69
Methotrexate	Folate analog metabolic inhibitor	7
Methylphenidate hydrochloride	Central nervous system stimulant	6
Metoprolol	beta-Adrenergic blocker	12
Metoprolol succinate	beta-Adrenergic blocker	8
Miebo		17
Mirtazapine		5
Morphabond Er		35
Morphine sulfate	Opioid agonist	9
Myrbetriq	beta3-Adrenergic agonist	7
Nifedipine	Dihydropyridine calcium channel blocker	16
Ofev	Kinase inhibitor	6
Olanzapine	Atypical antipsychotic	7
Omeprazole	Proton pump inhibitor	10
Oxycodone hydrochloride	Opioid agonist	6
OxyContin	Opioid agonist	27
Oxytrol for Women	Cholinergic muscarinic antagonist	10
Pancreatin		10
Pantoprazole	Proton pump inhibitor	5
Paxlovid		6
Pennsaid		6
Pentasa	Aminosalicylate	22
Potassium chloride	Osmotic laxative	61
Potassium citrate	Anti-coagulant	81
Pramipexole	Nonergot dopamine agonist	12
Prednisolone acetate	Corticosteroid	7
Prednisolone Acetate 1 0%		6
Premarin	Estrogen	9
Pristiq	Serotonin and norepinephrine reuptake inhibitor	23
Proair Hfa		10
Progesterone	Progesterone	5
Pyridostigmine bromide	Cholinesterase inhibitor	16
Qvar Redihaler	Corticosteroid	27
Restasis	Calcineurin inhibitor immunosuppressant	5
Rinvoq	Janus kinase inhibitor	447
Rivastigmine	Cholinesterase inhibitor	8
Rogaine		11
Rytary	Aromatic amino acid	22
Sandostatin	Somatostatin analog	9
Simbrinza	Carbonic anhydrase inhibitor	8
Sinemet	Aromatic amino acid	8
Sulfasalazine	Aminosalicylate	10
Symbicort	Corticosteroid	7
Tarpeyo	Corticosteroid	166
Testosterone	Androgen	11
Topiramate		5
Trelegy Ellipta	Anticholinergic	33
Tudorza Pressair	Anticholinergic	5
Tyvaso	Prostacycline vasodilator	8
Tyvaso DPI	Prostacycline vasodilator	34
Upadacitinib	Janus kinase inhibitor	92
Valproate sodium	Anti-epileptic agent	9
Vascepa		43
Vedolizumab	Integrin receptor antagonist	8
Venclexta	BCL-2 inhibitor	13
Venlafaxine	Serotonin and norepinephrine reuptake inhibitor	15
Venlafaxine hydrochloride	Serotonin and norepinephrine reuptake inhibitor	11
Vowst		8
Vyvanse	Central nervous system stimulant	7
Wellbutrin	Aminoketone	37
Wixela Inhub	Corticosteroid	6
Womens Rogaine		16
Womens Rogaine Unscented	Arteriolar vasodilator	43
Xeljanz	Janus kinase inhibitor	130
Xelstrym	Central nervous system stimulant	10
Xifaxan	Rifamycin antibacterial	5
Xigduo	Biguanide	11
Xiidra		28
Xulane	Estrogen	5
Yutrepia	Prostacycline vasodilator	16

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 42 pharmacologic classes with 10 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Product residue present name, in order of name
Class	Reports with this term
Aminoketone	112
Aminosalicylate	123
Androgen	11
Anti-coagulant	81
Anti-epileptic agent	61
Anticholinergic	48
Aromatic amino acid	599
Arteriolar vasodilator	43
Atypical antipsychotic	17
BCL-2 inhibitor	13
beta-Adrenergic blocker	20
beta2-Adrenergic agonist	33
Biguanide	130
Calcium channel blocker	11
Carbonic anhydrase inhibitor	24
Central alpha-2 adrenergic agonist	11
Central nervous system stimulant	39
Cholinergic muscarinic antagonist	14
Corticosteroid	259
Dihydropyridine calcium channel blocker	18
Dipeptidyl peptidase 4 inhibitor	18
Estrogen	230
Factor Xa inhibitor	14
Folate analog metabolic inhibitor	10
Gadolinium-based contrast agent	36
Histamine-1 receptor antagonist	16
Integrin receptor antagonist	12
Janus kinase inhibitor	671
Kinase inhibitor	35
Mood stabilizer	18
Nonergot dopamine agonist	18
Opioid agonist	68
Osmotic laxative	67
Partial opioid agonist	10
Phosphate binder	25
Prostacycline vasodilator	65
Prostaglandin analog	10
Proton pump inhibitor	19
Serotonin and norepinephrine reuptake inhibitor	105
Serotonin reuptake inhibitor	10
Sodium-Glucose cotransporter 2 inhibitor	13
Tumor necrosis factor blocker	41

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Product residue present, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Product residue present
Age	Reports	Share
Under 2	13	0.2%
2 to 11	37	0.7%
12 to 17	26	0.5%
18 to 44	466	8.9%
45 to 64	743	14.2%
65 to 74	539	10.3%
75 and over	410	7.8%
Age not given	2,998	57.3%

Sex of the patient in the reports that record Product residue present
Sex	Reports	Share
Female	2,724	52.1%
Male	1,637	31.3%
Unknown or not given	871	16.6%

Age and sex are as the report gives them. 87.3% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Product residue present: adverse event reports that record this term. https://reportedreactions.com/reaction/product-residue-present/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 1 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 1 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Oct 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Product residue present mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page